Formulation and investigation of 5-FU nanoparticles with factorial design-based studies

Farmaco

Volumn 60, Issue 10, 2005, Pages 840-846

  Bozkir, Asuman ^a   Saka, Ongun Mehmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

5 Fluorouracil; Biodegradable nanoparticles; In vitro distribution; Nanoprecipitation technique; Poly(lactide co glycolide)

Indexed keywords

ACETONE; FLUOROURACIL; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; POLOXAMER; POLYGLACTIN; RESOMER; SURFACTANT;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIFFUSION; DRUG ACTIVITY; DRUG FORMULATION; DRUG RESEARCH; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; STATISTICAL ANALYSIS; SURFACE PROPERTY; TECHNIQUE;

ANTI-INFECTIVE AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG DELIVERY SYSTEMS; DRUG DESIGN; FLUOROURACIL; GLYCOLATES; KINETICS; MODELS, CHEMICAL; NANOSTRUCTURES; PARTICLE SIZE; SOLUBILITY;

EID: 26944494899     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.06.016     Document Type: Article

References (25)

1. S. Muranishi, T. Fujita, M. Masahiro, and A. Yamamoto Potential for lymphatic targeting of peptides J. Control. Release 46 1997 157 164
2. B. Seijo, E. Fattal, L. Roblot-Treupel, and P. Couvreur Design of nanoparticles of less than 50:nm diameter: preparation, characterization and drug loading Int. J. Pharm. 62 1990 1 7
3. A. Bozkir, and O.M. Saka Chitosan nanoparticles for plasmid DNA delivery: effect of molecular structure of chitosan on formulation and release characteristics Drug Deliv. 11 2 2004 107 112
4. P. Jani, G.W. Halbert, J. Langridge, and A.T. Florence Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency J. Pharm. Pharmacol. 42 1990 821 826
5. M.D. Blanco, and M.J. Alonso Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres Eur. J. Pharm. Biopharm. 43 1997 287 294
6. A. Bozkir, G. Hayta, and O.M. Saka Multiple emulsions (w/o/w) and biodegradable nanoparticles containing influenza virus antigen: Immune response in rats Pharmazie 59 9 2004 723 725
7. C.J.H. Porter Drug delivery to the lymphatic system, Crit. Rev. Ther Drug Carr. Syst. 14 4 1997 333 393
8. P.D. Scholes, A.G.A. Coombes, L. Illum, S.S. Davis, M. Vert, and M.C. Davies The preparation of sub-200:nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery J. Control. Release 25 1993 145 153
9. H. Harashima, K. Sakata, K. Funato, and H. Kiwada Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes Pharm. Res. 11 3 1994 402 406
10. S.M. Moghimi, A.E. Hawley, N.M. Christy, T. Gray, L. Illum, and S.S. Davis Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes FEBS Lett. 344 1 1994 25 30
11. A.E. Hawley, L. Illum, and S.S. Davis Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake Pharm. Res. 14 5 1997 657 661
12. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 4 1999 471 476
13. Y. Nakamoto, M. Hashida, S. Muranishi, and H. Sezaki Studies on pharmaceutical modification of anticancer agents. II enhanced delivery of bleomycin into lymph by emulsions and drying emulsions Chem. Pharm. Bull. (Tokyo) 25 1975 2410 2418
14. R. Jeyanthi, and P. Rao Release characteristics of bleomycin, mitomycin C and 5-fluorouracil from gelatin microspheres Int. J. Pharm. 55 1989 31 37
15. E. Hirao, T. Saito, and M. Kobayashi Selective delivery of pepleomycin to esophageal lymph nodes by activated carbon particles Anticancer Res. 13 1993 991 994
16. A. Hagiwara, T. Ahn, T. Ueda, A. Iwamoto, T. Ueda, T. Torii, and T. Takahashi Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases Anticancer Res. 6 1985 1005 1008
17. M. Nichifor, E.H. Schacht, and L.W. Seymor Polymeric prodrugs of 5-fluorouracil J. Control. Release 48 1997 165 178
18. K. Ciftci, A.A. Hincal, S.H. Kas, T.M. Ercan, and S. Ruacan "Microspheres of 5-fluorouracil using poly(dl-lactic acid):in vitro release properties and distribution in mace after in i.v. administration" Eur. J. Pharm. Sci. 1994 1 1994 249 258
19. K. Ciftci, S.H. Kas, A.A. Hincal, T.M. Ercan, O. Güven, and S. Ruacan In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method Int. J. Pharm. 131 1996 73 82
20. J.A. Omotosho, T.L. Whateley, T.K. Law, and A.T. Florence The nature of the oil phase and the release of solutes from multiple (w/o/w) emulsions J. Pharm. Pharmacol. 38 1986 865 870
21. P. Wehrle, B. Magenheim, and S. Benita The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design Eur. J. Pharm. Biopharm. 41 1 1995 19 26
22. National committee for clinical laboratory standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 1997 Approved Standard M7-A4 Villanova, PA
23. National committee for clinical laboratory standards Reference method for broth dilution antifungal susceptibility testing of yeasts 1997 Approved standard. M27-A4 Villanova, PA
24. M.F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M.J. Alonso, P. Labrude, and C. Vigneron Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method J. Control. Release 50 1998 31 40
25. H.S. Yoo, J.E. Oh, K.H. Lee, and T.G. Park Biodegradable nanoparticles containing doxurubicin-PLGA conjugate for sustained release Pharm. Res. 16 7 1999 1114 1118